Susquehanna International Group
IDYA icon

Susquehanna International Group’s IDEAYA Biosciences IDYA Stock Holding History

Susquehanna International Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
46,709
-16,849
-27% -$565K ﹤0.01% 6777
2025
Q4 		$2.2M Buy
63,558
+18,234
+40% +$581K ﹤0.01% 5455
2025
Q3 		$1.23M Sell
45,324
-98,621
-69% -$2.39M ﹤0.01% 6843
2025
Q2 		$3.03M Buy
143,945
+14,210
+11% +$273K ﹤0.01% 4936
2025
Q1 		$2.13M Buy
129,735
+79,108
+156% +$1.69M ﹤0.01% 5393
2024
Q4 		$1.3M Buy
50,627
+15,571
+44% +$441K ﹤0.01% 6320
2024
Q3 		$1.11M Buy
35,056
+5,501
+19% +$209K ﹤0.01% 6546
2024
Q2 		$1.04M Sell
29,555
-8,054
-21% -$319K ﹤0.01% 6498
2024
Q1 		$1.65M Buy
37,609
+6,907
+22% +$297K ﹤0.01% 5776
2023
Q4 		$1.09M Buy
30,702
+11,370
+59% +$339K ﹤0.01% 6777
2023
Q3 		$522K Sell
19,332
-17,763
-48% -$450K ﹤0.01% 8129
2023
Q2 		$872K Sell
37,095
-26,808
-42% -$551K ﹤0.01% 7016
2023
Q1 		$877K Buy
63,903
+51,289
+407% +$854K ﹤0.01% 7167
2022
Q4 		$229K Sell
12,614
-30,659
-71% -$516K ﹤0.01% 9779
2022
Q3 		$646K Buy
43,273
+9,330
+27% +$121K ﹤0.01% 7769
2022
Q2 		$468K Buy
33,943
+1,289
+4% +$14.3K ﹤0.01% 8431
2022
Q1 		$365K Sell
32,654
-8,849
-21% -$130K ﹤0.01% 9766
2021
Q4 		$981K Buy
41,503
+24,688
+147% +$573K ﹤0.01% 7350
2021
Q3 		$429K Buy
+16,815
New +$393K ﹤0.01% 9768
2021
Q2 		– Sell
-10,739
Closed -$252K – 12871
2021
Q1 		$252K Buy
10,739
+202
+2% +$3.9K ﹤0.01% 10966
2020
Q4 		$148K Sell
10,537
-6,421
-38% -$87K ﹤0.01% 10259
2020
Q3 		$213K Buy
+16,958
New +$210K ﹤0.01% 9356
2020
Q2 		– Sell
-19,240
Closed -$79K – 10471
2020
Q1 		$79K Buy
19,240
+6,502
+51% +$46K ﹤0.01% 9454
2019
Q4 		$96K Buy
+12,738
New +$90.9K ﹤0.01% 9159

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Susquehanna International Group's IDYA Position: Q1 2026 in Review

Susquehanna International Group reduced its IDEAYA Biosciences (IDYA) stake by 27% in Q1 2026, selling an estimated $565K and leaving 46,709 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #6777.

Susquehanna International Group first reported a position in IDYA in Q4 2019 and has held it in 24 quarters since. The position peaked at $3.03M in Q2 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Susquehanna International Group held 46,709 shares of IDEAYA Biosciences worth $1.56M as of Q1 2026.
  • Susquehanna International Group sold 16,849 IDEAYA Biosciences shares in Q1 2026, an estimated $565K.
  • IDEAYA Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6777 holding.
  • Susquehanna International Group first reported a position in IDEAYA Biosciences in Q4 2019 and has held it in 24 quarters since.
  • Susquehanna International Group's IDEAYA Biosciences position peaked at $3.03M in Q2 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.